- Institution
- 경상남도 사천시
- Department
- 치매관리과
◎고압산소치료운영비사업 225,000,000원
Programme 고압산소 치료 운영비 지원사업
Amounts and period
- Budgeted amount
- 225,000,000 KRW
- 전년도예산액
- Present in the source but not extracted
- Change
- Not comparable
Changes are calculated only when both amounts are known in full. No percentage is calculated when the comparison amount is zero.
Programme hierarchy and share
The selected item’s share of each parent budget, calculated from amounts in the same source document.
A share is not calculated for missing or partial amounts, non-positive parent amounts, or an item amount greater than its parent.
-
Department 치매관리과 3,568,736,000 KRW6.3%
-
Policy 의약무관리 및 공공의료 1,658,880,000 KRW13.6%
-
Programme 의약무관리 및 공공의료 1,658,880,000 KRW13.6%
-
Project 고압산소 치료 운영비 지원사업 225,000,000 KRW100.0%
-
Budget category 민간이전 225,000,000 KRW100.0%
-
Statistical item 민간경상사업보조 225,000,000 KRW100.0%
-
Item ◎고압산소치료운영비사업 225,000,000원 225,000,000 KRW
- Category–statistical code
- 307-02
- Group
- Not provided in source
Original description
Not provided in source
Institution and programme names are shown as the original Korean source text.
Detailed budget items
1 itemsData source
-
Open source PDF
경상남도 사천시 · FY2022 본예산 · 일반회계 · 060_2022년당초예산 2022년 당초예산 세출예산사업명세서 새 창에서 열림
Opens in a new window
- Page
- 14 / 16
- Document ID
doc_1mrgcgka7ftsqej66srf4qgk1b- Source document status
- Available
- File type
- application/pdf
- File size
- 254.182 KiB
- Location inside the source
- Page 14 Row 10 Line 1 Column level4
Source and reference
FY 2022 release No source record
- Fiscal year of record
- 2022
- Fetched from the source
- 2026-07-29 12:09
- Read and interpreted
- 2026-07-29 12:09
- Query snapshot refreshed
- 2026-09-02 03:23
- Item ID
bi_6y6gjvzj40vnj3kfr5te6tvajm- Address of this item
- /en/BudgetDetail/Item/bi_6y6gjvzj40vnj3kfr5te6tvajm
Related records
Similar budgets
Keyword “고압산소치료운영비사업” · classification 307-02
No items with the same classification were found among the candidates checked.
AI analysis report
AI analysis reports are not yet available.